Figure 1: The distribution of secondary BSI rates in VAPs/VAEs caused by E. coli and K. pneumoniae by ESBL production and year, Turkey, 2014–2019 (n=11,453)
Figure 1: The distribution of secondary BSI rates in VAPs/VAEs caused by E. coli and K. pneumoniae by ESBL production and year, Turkey, 2014–2019 (n=11,453)